BSX Losses? May 4, 2026 Deadline Nears for Boston Scientific Securities Class Action

Faruqi & Faruqi, LLP, a prominent national securities law firm, has initiated an investigation into potential claims against Boston Scientific Corporation (NYSE: BSX). The firm is urging investors who incurred losses in Boston Scientific securities purchased between July 23, 2025, and February 3, 2026, to contact Securities Litigation Partner James (Josh) Wilson to discuss their legal options.

This investigation follows the filing of a federal securities class action against Boston Scientific. Investors are also reminded that May 4, 2026, is the deadline to seek appointment as lead plaintiff in this ongoing legal proceeding. Those wishing to discuss their rights can reach Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

From a quantitative perspective, Boston Scientific (NYSE: BSX) currently holds an RS Score of 51.96, placing it in the 10.20th percentile within its country and the 7.14th percentile within its sector. Analysis of its underlying section scores reveals that Profitability is strong at 80.40. However, the stock shows weaker performance in other key areas, with Valuation at 46.92, Growth at 14.10, Momentum at 8.38, and EPS Revisions at 70.00. Want to discover which stocks rank the highest? Start your free 7-day trial at rankedstocks.com.